Can trade names be mentioned to provide important background on treatment approaches for a specific condition (not to push a current treatment recommendation)?

The ACCME does not prohibit any use of trade names, but it does take a use-sparingly, only-if-necessary approach.  Aim to limit trade names to one or very limited mentions, use text only (no logos/branding), and reference comparable products/services, as highlighting only one trade name among several could be construed as a form of preference or promotion.